Insiders · RNXT

RNXT insider transactions

RenovoRx Inc. (RNXT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RNXT

• 21d
  Chief Financial Officer Voll Mark bought $19,690 worth of shares (25,000 units at $0.79), increasing direct ownership by 21% to 142,380 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 64d
  SEC Form 4 filed by Bagai Shaun

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 64d
  SEC Form 4 filed by Voll Mark

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 64d
  SEC Form 4 filed by Gentry Leesa

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 64d
  SEC Form 4 filed by Agah Ramtin

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 76d
  SEC Form 4 filed by Voll Mark

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 76d
  Amendment: SEC Form 3 filed by new insider Voll Mark

  3/A - RenovoRx, Inc. (0001574094) (Issuer)
• 78d
  SEC Form 4 filed by Marton Laurence

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 78d
  SEC Form 4 filed by Bagai Shaun

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 78d
  SEC Form 4 filed by Voll Mark

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 78d
  SEC Form 3 filed by new insider Voll Mark

  3 - RenovoRx, Inc. (0001574094) (Issuer)
• 140d
  Chief Medical Officer Agah Ramtin bought $9,975 worth of shares (10,000 units at $1.00), increasing direct ownership by 1% to 798,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 157d
  Chief Medical Officer Agah Ramtin bought $8,424 worth of shares (9,795 units at $0.86), increasing direct ownership by 1% to 788,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 160d
  Chief Medical Officer Agah Ramtin bought $169 worth of shares (205 units at $0.83), increasing direct ownership by 0.03% to 778,665 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 171d
  Chief Executive Officer Bagai Shaun bought $4,506 worth of shares (5,000 units at $0.90), increasing direct ownership by 1% to 340,040 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 174d
  Chief Executive Officer Bagai Shaun bought $4,262 worth of shares (5,000 units at $0.85), increasing direct ownership by 2% to 335,040 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 176d
  Chief Medical Officer Agah Ramtin bought $10,200 worth of shares (12,000 units at $0.85), increasing direct ownership by 2% to 778,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 185d
  Chief Medical Officer Agah Ramtin bought $9,600 worth of shares (10,000 units at $0.96), increasing direct ownership by 1% to 766,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 198d
  Chief Medical Officer Agah Ramtin bought $17,600 worth of shares (22,000 units at $0.80), increasing direct ownership by 3% to 756,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 251d
  SEC Form 4 filed by Director Marton Laurence

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 251d
  SEC Form 4 filed by Director Macfarlane K. Angela

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 251d
  SEC Form 4 filed by Director Ryan Una S

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 251d
  SEC Form 4 filed by Director Spiegel Robert J.

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 289d
  Chief Executive Officer Bagai Shaun bought $9,296 worth of shares (10,000 units at $0.93), increasing direct ownership by 3% to 330,040 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 343d
  SEC Form 4 filed by Chief Executive Officer Bagai Shaun

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 343d
  SEC Form 4 filed by Chief Medical Officer Agah Ramtin

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 343d
  SEC Form 4 filed by Chief Clinical Officer Gentry Leesa

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 343d
  SEC Form 4 filed by VP, Controller and PAO Kocak Ron

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 367d
  Chief Medical Officer Agah Ramtin bought $29,400 worth of shares (21,000 units at $1.40), increasing direct ownership by 3% to 734,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 370d
  Chief Medical Officer Agah Ramtin gifted 400,000 shares, decreasing direct ownership by 36% to 713,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 401d
  Director Marton Laurence exercised 20,480 shares at a strike of $0.15, increasing direct ownership by 45% to 66,164 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 420d
  Chief Medical Officer Agah Ramtin bought $13,500 worth of shares (15,000 units at $0.90), increasing direct ownership by 1% to 1,113,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 421d
  SEC Form 4 filed by Chief Executive Officer Bagai Shaun

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 421d
  SEC Form 4 filed by VP, Controller and PAO Kocak Ron

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 421d
  SEC Form 4 filed by Chief Clinical Officer Gentry Leesa

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 421d
  SEC Form 4 filed by Chief Medical Officer Agah Ramtin

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 421d
  Chief Executive Officer Bagai Shaun bought $6,821 worth of shares (7,500 units at $0.91), increasing direct ownership by 2% to 320,040 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 423d
  Chief Medical Officer Agah Ramtin bought $16,000 worth of shares (20,000 units at $0.80), increasing direct ownership by 2% to 1,098,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 426d
  VP Controller and PAO Kocak Ron bought $10,011 worth of shares (12,595 units at $0.79) (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 427d
  Chief Medical Officer Agah Ramtin bought $24,399 worth of shares (30,000 units at $0.81), increasing direct ownership by 3% to 1,078,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 427d
  Chief Executive Officer Bagai Shaun bought $8,300 worth of shares (10,000 units at $0.83), increasing direct ownership by 3% to 312,540 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 427d
  Director Marton Laurence bought $10,218 worth of shares (12,050 units at $0.85), increasing direct ownership by 36% to 45,684 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 428d
  Chief Medical Officer Agah Ramtin bought $21,840 worth of shares (26,000 units at $0.84) (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 429d
  Chief Executive Officer Bagai Shaun bought $8,300 worth of shares (10,000 units at $0.83), increasing direct ownership by 3% to 302,540 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 617d
  SEC Form 4 filed by Director Ryan Una S

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 617d
  SEC Form 4 filed by Director Spiegel Robert J.

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 617d
  SEC Form 4 filed by Director Marton Laurence

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 617d
  SEC Form 4 filed by Director Macfarlane K. Angela

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 825d
  SEC Form 4 filed by Gentry Leesa

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 825d
  SEC Form 3 filed by new insider Gentry Leesa

  3 - RenovoRx, Inc. (0001574094) (Issuer)
• 849d
  SEC Form 4 filed by Kocak Ron

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 849d
  SEC Form 3 filed by new insider Kocak Ron

  3 - RenovoRx, Inc. (0001574094) (Issuer)
• 862d
  Agah Ramtin bought 40,983 shares, increasing direct ownership by 633% to 47,460 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 862d
  Spiegel Robert J. bought 40,983 shares (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 862d
  Bagai Shaun bought 40,983 shares, increasing direct ownership by 16% to 292,540 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 862d
  Marton Laurence bought 8,196 shares, increasing direct ownership by 32% to 33,634 units (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 862d
  Macfarlane K. Angela bought 40,983 shares (SEC Form 4)

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 869d
  SEC Form 4 filed by Bagai Shaun

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 869d
  SEC Form 4 filed by Nelms Angela

  4 - RenovoRx, Inc. (0001574094) (Issuer)
• 869d
  SEC Form 4 filed by Agah Ramtin

  4 - RenovoRx, Inc. (0001574094) (Issuer)